Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1991 1
1992 3
1993 4
1994 8
1995 13
1996 7
1997 6
1998 17
1999 6
2000 14
2001 15
2002 23
2003 16
2004 7
2005 12
2006 6
2007 11
2008 20
2009 24
2010 26
2011 25
2012 21
2013 21
2014 12
2015 23
2016 33
2017 26
2018 20
2019 16
2020 27
2021 27
2022 23
2023 17
2024 9

Text availability

Article attribute

Article type

Publication date

PubMed for id: 3716

492 results

Results by year

Filters applied: . Clear all
Page 1
Individuals with JAK1 variants are affected by syndromic features encompassing autoimmunity, atopy, colitis, and dermatitis.
Horesh ME, Martin-Fernandez M, Gruber C, Buta S, Le Voyer T, Puzenat E, Lesmana H, Wu Y, Richardson A, Stein D, Hodeib S, Youssef M, Kurowski JA, Feuille E, Pedroza LA, Fuleihan RL, Haseley A, Hovnanian A, Quartier P, Rosain J, Davis G, Mullan D, Stewart O, Patel R, Lee AE, Rubinstein R, Ewald L, Maheshwari N, Rahming V, Chinn IK, Lupski JR, Orange JS, Sancho-Shimizu V, Casanova JL, Abul-Husn NS, Itan Y, Milner JD, Bustamante J, Bogunovic D. Horesh ME, et al. J Exp Med. 2024 Jun 3;221(6):e20232387. doi: 10.1084/jem.20232387. Epub 2024 Apr 2. J Exp Med. 2024. PMID: 38563820
JAK1 promotes HDV replication and is a potential target for antiviral therapy.
Heuschkel MJ, Bach C, Meiss-Heydmann L, Gerges E, Felli E, Giannone F, Pessaux P, Schuster C, Lucifora J, Baumert TF, Verrier ER. Heuschkel MJ, et al. J Hepatol. 2024 Feb;80(2):220-231. doi: 10.1016/j.jhep.2023.10.030. Epub 2023 Nov 2. J Hepatol. 2024. PMID: 37925078 Free article.
JAK1 Inhibition to Treat Crohn's Disease.
Abreu MT. Abreu MT. N Engl J Med. 2023 May 25;388(21):2005-2009. doi: 10.1056/NEJMe2301147. N Engl J Med. 2023. PMID: 37224204 No abstract available.
Partial human Janus kinase 1 deficiency predominantly impairs responses to interferon gamma and intracellular control of mycobacteria.
Daza-Cajigal V, Albuquerque AS, Young DF, Ciancanelli MJ, Moulding D, Angulo I, Jeanne-Julien V, Rosain J, Minskaia E, Casanova JL, Boisson-Dupuis S, Bustamante J, Randall RE, McHugh TD, Thrasher AJ, Burns SO. Daza-Cajigal V, et al. Front Immunol. 2022 Sep 9;13:888427. doi: 10.3389/fimmu.2022.888427. eCollection 2022. Front Immunol. 2022. PMID: 36159783 Free PMC article.
A novel activating JAK1 mutation in chronic eosinophilic leukemia.
Shomali W, Damnernsawad A, Theparee T, Sampson D, Morrow Q, Yang F, Fernandez-Pol S, Press R, Zehnder J, Tyner JW, Gotlib J. Shomali W, et al. Blood Adv. 2021 Sep 28;5(18):3581-3586. doi: 10.1182/bloodadvances.2021004237. Blood Adv. 2021. PMID: 34496019 Free PMC article.
492 results